Myron J. Levin

30.3k total citations · 5 hit papers
302 papers, 17.2k citations indexed

About

Myron J. Levin is a scholar working on Epidemiology, Infectious Diseases and Dermatology. According to data from OpenAlex, Myron J. Levin has authored 302 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 248 papers in Epidemiology, 55 papers in Infectious Diseases and 55 papers in Dermatology. Recurrent topics in Myron J. Levin's work include Herpesvirus Infections and Treatments (178 papers), Cytomegalovirus and herpesvirus research (60 papers) and Acne and Rosacea Treatments and Effects (36 papers). Myron J. Levin is often cited by papers focused on Herpesvirus Infections and Treatments (178 papers), Cytomegalovirus and herpesvirus research (60 papers) and Acne and Rosacea Treatments and Effects (36 papers). Myron J. Levin collaborates with scholars based in United States, United Kingdom and Canada. Myron J. Levin's co-authors include Michael N. Oxman, Adriana Weinberg, Anthony Hayward, Christopher S. Ambrose, Harley A. Rotbart, Harry Keyserling, E. Graham Davies, Per Ljungman, Insoo Kang and Robin K. Avery and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Myron J. Levin

296 papers receiving 16.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

2013 1.1k citations Myron J. Levin et al. profile →
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

2015 906 citations Myron J. Levin, Toufik Zahaf et al. profile →
Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

2014 649 citations Myron J. Levin et al. profile →
Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children

1993 583 citations Myron J. Levin et al. profile →
Efficacy Results of a Trial of a Herpes Simplex Vaccine

2012 376 citations Myron J. Levin et al. profile →

Peers

Countries citing papers authored by Myron J. Levin

Since Specialization

Citations

This map shows the geographic impact of Myron J. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myron J. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myron J. Levin more than expected).

Fields of papers citing papers by Myron J. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myron J. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myron J. Levin. The network helps show where Myron J. Levin may publish in the future.

Co-authorship network of co-authors of Myron J. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of Myron J. Levin. A scholar is included among the top collaborators of Myron J. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myron J. Levin. Myron J. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Clinical and Economic Comparison of Cell-Based Versus Recombinant Influenza Vaccines in Adults 18–64 Years in the United States 2024 ·Vaccines ·Myron J. Levin, (unknown), (unknown), (unknown), Richard M. Zur, Emily B. Kahn, (unknown), (unknown)	0
2	Effect of high dose vitamin D supplementation on subsequent immune responses to administration of the live herpes zoster vaccine to long-term care residents 2024 ·Vaccine ·Myron J. Levin, Adit A. Ginde, D. Scott Schmid, Nancy Lang, Jennifer Canniff, Robert S. Schwartz, Adriana Weinberg	0
3	Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity 2023 ·Journal of Clinical Investigation ·Kerry J. Laing, Emily S. Ford, Michael Johnson, Myron J. Levin, David M. Koelle, Adriana Weinberg	10
4	Innate and Adaptive Cell-Mediated Immune Responses to a COVID-19 mRNA Vaccine in Young Children 2023 ·Open Forum Infectious Diseases ·Adriana Weinberg, Michael Johnson, (unknown), Elena W.Y. Hsieh, Ross M. Kedl, Daniela Weiskopf, (unknown), (unknown), (unknown), Ryan M. Baxter, Myron J. Levin	1
5	Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials 2020 ·Lara D. Veeken ·Alemnew F. Dagnew, (unknown), Caroline Hervé, Toufik Zahaf, Myron J. Levin, Anne Schuind, (unknown)	42
6	Evaluation of two frailty indices, with practical application in a vaccine clinical trial 2019 ·Human Vaccines & Immunotherapeutics ·Desmond Curran, Melissa K. Andrew, Myron J. Levin, (unknown), Sean Matthews, Charles Fogarty, Nicola P. Klein, (unknown), Lidia Oostvogels, Kenneth E. Schmader	8
7	Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults 2019 ·Human Vaccines & Immunotherapeutics ·Adriana Weinberg, Stacie Lambert, Jennifer Canniff, Yu Li, Nancy Lang, Mark T. Esser, Judith Falloon, Myron J. Levin	4
8	A Phase I Study of the SMAC-Mimetic Birinapant in Adults with Refractory Solid Tumors or Lymphoma 2015 ·Molecular Cancer Therapeutics ·Ravi K. Amaravadi, Russell J. Schilder, Lainie P. Martin, Myron J. Levin, Martin A. Graham, David Weng, Alex A. Adjei	101
9	Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women 2015 ·AIDS Research and Human Retroviruses ·Adriana Weinberg, Petronella Muresan, Kelly M. Richardson, Terence Fenton, (unknown), A. Anthony Bloom, D. Heather Watts, Mark J. Abzug, Sharon Nachman, Myron J. Levin, (unknown)	1
10	Major depressive disorder and immunity to varicella-zoster virus in the elderly 2011 ·Brain Behavior and Immunity ·Michael R. Irwin, Myron J. Levin, Carmen Carrillo, Richard G. Olmstead, (unknown), Nancy Lang, Michael J. Caulfield, Adriana Weinberg, Ivan S. F. Chan, J. Benjamin St. Clair, (unknown), Rocio D. Marchese, Heather Williams, (unknown), (unknown), Gary R. Johnson, Michael N. Oxman	62
11	Predictors of Postherpetic Neuralgia Among Patients With Herpes Zoster: A Prospective Study 2010 ·Journal of Pain ·Mélanie Drolet, Marc Brisson, Kenneth E. Schmader, Myron J. Levin, Robert W. Johnson, Michael N. Oxman, David M. Patrick, Stéphanie Camden, James A. Mansi	94
12	T Cell Responses of HIV-Infected Children after Administration of Inactivated or Live Attenuated Influenza Vaccines 2010 ·AIDS Research and Human Retroviruses ·Adriana Weinberg, Lin‐Ye Song, Terence Fenton, Sharon Nachman, Jennifer S. Read, (unknown), Myron J. Levin	7
13	Sleep Disturbance and Depression Recurrence in Community-Dwelling Older Adults: A Prospective Study 2008 ·American Journal of Psychiatry ·Hyong Jin Cho, Helen Lavretsky, Richard G. Olmstead, Myron J. Levin, Michael N. Oxman, Michael R. Irwin	237
14	Cell-Mediated Immune (CMI) Responses and Zoster-associated Pain in Herpes Zoster (HZ) Patients 2007 ·Myron J. Levin	1
15	Cytomegalovirus-Specific Cell-Mediated Immunity in HIV-Infected Children on HAART 2006 ·AIDS Research and Human Retroviruses ·Adriana Weinberg, Andrew Wiznia, Bonnie LaFleur, (unknown), Myron J. Levin	5
16	Varicella-Zoster Virus Activates Inflammatory Cytokines in Human Monocytes and Macrophages via Toll-Like Receptor 2 2005 ·Journal of Virology ·Jennifer Wang, Evelyn A. Kurt‐Jones, Ok Sarah Shin, (unknown), Myron J. Levin, Robert W. Finberg	133
17	Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory 2004 ·Journal of Pain ·Paul Coplan, Kenneth E. Schmader, Alexander Nikas, Ivan S. F. Chan, Peter W. Choo, Myron J. Levin, Gary R. Johnson, Mark S. Bauer, Heather Williams, Karen M. Kaplan, Harry A. Guess, Michael N. Oxman	237
18	Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-Infected Infants and Children 1998 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·John S. Lambert, James McNamara, Samuel L. Katz, Terry Fenton, Minhee Kang, Thomas C. VanCott, Robert A. Livingston, Elizabeth Hawkins, Jack Moye, William Borkowsky, Daniel Johnson, Ram Yogev, (unknown), (unknown), Anne A. Gershon, Diane W. Wara, (unknown), Myron J. Levin, George McSherry, Gale Smith	25
19	Cellular Immunity to Varicella‐Zoster Virus in Patients with Major Depression 1998 ·The Journal of Infectious Diseases ·Michael R. Irwin, (unknown), Heather Williams, (unknown), Christina Y. Chan, (unknown), Myron J. Levin, Anthony Hayward, Michael N. Oxman	78
20	Unsuspected varicella-zoster virus encephalitis in a child with acquired immunodeficiency syndrome 1993 ·The Journal of Pediatrics ·Christopher C. Silliman, D G Tedder, John W. Ogle, Jack H. Simon, Bette K. Kleinschmidt‐DeMasters, Marilyn J. Manco‐Johnson, Myron J. Levin	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact